Facebook
Messenger
Twitter
LinkedIn
Email
PrintPancreatic Cancer
Drs. Mark Truty and Robert McWilliams explain how new and improved treatment methods are helping people with pancreatic cancer live longer.
Researchers have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.
A new blog series to raise awareness about clinical trials and their important role in cancer care.
Study finds radiomics-based machine learning models may detect pancreatic cancer on CT scans earlier than current methods for diagnosis.
Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.
La tasa de supervivencia a cinco años para el cáncer de páncreas es solo del 10,8 %. Aquí hay cinco cosas que todos deberían saber sobre este cáncer mortal.
A recent study provides support for Mayo Clinic's use of positron emission tomography (PET) to guide pancreatic cancer treatment decisions.
A new Mayo Clinic study finds 1 in 6 people with pancreatic cancer harbor inherited genetic mutations.
Physician assistant Casey Swanson responds to a question about cancer risk and genetic testing for a BRCA2 mutation.
The five-year survival rate for pancreatic cancer is just 10.8%. Here are five things everyone should know about this deadly cancer.